Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion

World Journal of Surgery

Volumn 27, Issue 4, 2003, Pages 455-459

  Higashi, Hiroshi ^a   Natsugoe, Shoji ^a   Ishigami, Sumiya ^a   Uenosono, Yoshikazu ^a   Matsumoto, Masataka ^a   Nakajo, Akihiro ^a   Miyazono, Futoshi ^a   Hokita, Shuichi ^a   Takao, Sonshin ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN;

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER SURGERY; CELL TYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; STOMACH CANCER; SUBMUCOSA;

ADENOCARCINOMA; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0042243548     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6601-4     Document Type: Article

References (24)

1. Hisamichi S, Sugawara N. Mass screening for gastric cancer by x-ray examination. Jpn. J. Clin. Oncol. 1984;14:211-223
2. Muta Y, Baba Y, Nishiyama M, et al. Characteristics and progress of treatment for gastric cancers detected by mass screening. Gan To Kagaku Ryoho 1998;25:1505-1513
3. Maehara Y, Okuyama T, Moriguchi S, et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 1992;70:392-395
4. Ohta K, Ohyama S, Nakajima T. State of the arts of gastric cancer surgery in cancer institute hospital. J. Cancer Clin. 1999;45:709-714
5. Harrison LE, Choe JK, Goldstein M, et al. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J. Surg. Oncol. 2000;73:153-157
6. Maehara Y, Oshiro T, Endo K, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402
7. Ishida K, Katsuyama T, Sugiyama A, et al. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-1076
8. Woodcock-Mitchell J, Eichner R, Nelson WG, et al. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell Biol. 1982;95:580-588
9. Listrom MB, Dalton LW. Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2. Am. J. Clin. Pathol. 1987;88:297-301
10. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984;32:219-229
11. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. In Gastric Cancer, 2nd English edition, 1998;1-15
12. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 1992;127:392-399
13. Morton DL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it a standard of care? J. Am. Coll. Surg. 1999;189:214-223
14. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994;220:391-401
15. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J.A.M.A. 1996;276:1818-1822
16. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-1867
17. Nakajo A, Natsugoe S, Ishigami S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pNO gastric cancer. Ann. Surg. Oncol. 2001;8:158-162
18. Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann. Surg. Oncol. 1997;4:447-451
19. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis. Colon Rectum 1991;34:917-920
20. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer 1994;73:563-569
21. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N. Engl. J. Med. 1997;337:1188-1194
22. Natsugoe S, Mueller J, Stein HJ, et al. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998;83:858-866
23. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769-778
24. Natsugoe S, Aikou T, Higashi Y, et al. The concept of lymph node micrometastasis for sentinel node navigation surgery. J. Clin. Surg. 2000;55:317-322